A Comparative Randomized Single-Blind Placebo-controlled Study of the Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Single Escalating Subcutaneous Doses of BCD 121 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2017
At a glance
- Drugs BCD 121 (Primary)
- Indications Rheumatoid arthritis
- Focus First in man; Pharmacokinetics
- Sponsors Biocad
- 14 Jul 2017 Status changed from active, no longer recruiting to completed.
- 31 Mar 2017 Status changed from planning to active, no longer recruiting.
- 14 Jul 2016 New trial record